Skip to main content
Veterinary Medicines

Acticarp 50 mg/ml, Solution for Injection

Authorised
  • Carprofen

Product identification

Medicine name:
Acticarp 50 mg/ml, Solution for Injection
Acticarp 50 mg/ml Soluzione iniettabile per bovini
Active substance:
  • Carprofen
Target species:
  • Cattle
Route of administration:
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Carprofen
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Milk
        0
        hour
      • Meat and offal
        21
        day
  • Subcutaneous use
    • Cattle
      • Milk
        0
        hour
      • Meat and offal
        21
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AE91
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • 50 ml amber glass (Type I) vial closed with Flurotec (coated chlorobutyl) rubber stopper and aluminium flip off. One vial in a carton box.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ecuphar
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratori Fundacio Dau
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 104397
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0156/001
Concerned member states:
  • Austria
  • Belgium
  • France
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Poland
  • Portugal
  • Slovakia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 8/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."